Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Critical Limb Ischemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Critical Limb Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Critical Limb Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
153 pages
Japanese Encephalitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Japanese Encephalitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Japanese Encephalitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
46 pages
Corneal Neovascularization - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Corneal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Corneal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
41 pages
Hepatitis D - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hepatitis D (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis D and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
95 pages
Pompe Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pompe Disease (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Pompe Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
102 pages
Neurofibromatoses Type II - Pipeline Review, H1 2020
US$ 2,000.00
... . The Neurofibromatoses Type II (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neurofibromatoses Type II and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
44 pages
Binge Eating Disorder - Pipeline Review, H1 2020
US$ 2,000.00
... . The Binge Eating Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Binge Eating Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development ...
April 2020
62 pages
Hairy Cell Leukemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hairy Cell Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hairy Cell Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
125 pages
Retinoblastoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Retinoblastoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Retinoblastoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
67 pages
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Adrenocortical Carcinoma (Adrenal Cortex Cancer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
162 pages
Chronic Urticaria Or Hives - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chronic Urticaria Or Hives (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Urticaria Or Hives and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
140 pages
Organophosphate and Carbamate Poisoning - Pipeline Review, H1 2020
US$ 2,000.00
... . The Organophosphate and Carbamate Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Organophosphate and Carbamate Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development ...
April 2020
38 pages
Pheochromocytoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pheochromocytoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pheochromocytoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
112 pages
Ureter Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ureter Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ureter Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
298 pages
Gastroenteritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gastroenteritis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastroenteritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
97 pages
Neisseria meningitidis Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Neisseria meningitidis Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Neisseria meningitidis Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
93 pages
Keratitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Keratitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Keratitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
84 pages
Guillain-Barre Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Guillain-Barre Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Guillain-Barre Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
62 pages
Rett Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Rett Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Rett Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
182 pages
Behcet Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Behcet Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Behcet Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
65 pages
Hypertrophic Cardiomyopathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypertrophic Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Hypertrophic Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
88 pages
Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H1 2020
US$ 2,000.00
... -Occlusive Crisis Associated With Sickle Cell Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Vaso-Occlusive Crisis Associated With Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
April 2020
83 pages
Ventricular Tachycardia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ventricular Tachycardia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ventricular Tachycardia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
53 pages
Kidney Transplant Rejection - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Kidney Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Kidney Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
172 pages
Chikungunya Fever - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chikungunya Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chikungunya Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
126 pages
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
552 pages
Adenosine Receptor A3 - Pipeline Review, H1 2020
US$ 3,500.00
Adenosine Receptor A3 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Adenosine Receptor A3 - Pipeline Review, H1 2020'; Adenosine Receptor A3 (ADORA3) pipeline Target...
April 2020
85 pages
Cathepsin B - Pipeline Review, H1 2020
US$ 3,500.00
Cathepsin B - Pipeline Review, H1 2020 SUMMARY Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molec...
April 2020
32 pages
Cathepsin L1 - Pipeline Review, H1 2020
US$ 3,500.00
Cathepsin L1 - Pipeline Review, H1 2020 SUMMARY Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Cathepsin L, a lysosomal endopeptidase is a member of the papain-like f...
April 2020
33 pages
Cathepsin S - Pipeline Review, H1 2020
US$ 3,500.00
Cathepsin S - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Cathepsin S - Pipeline Review, H1 2020'; Cathepsin S (CTSS or EC 3.4.22.27) pipeline Target constitutes clo...
April 2020
33 pages
Coagulation Factor XI - Pipeline Review, H1 2020
US$ 3,500.00
Coagulation Factor XI - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Coagulation Factor XI - Pipeline Review, H1 2020'; Coagulation Factor XI (Plasma Thromboplastin A...
April 2020
69 pages
Collagenase 3 - Pipeline Review, H1 2020
US$ 3,500.00
Collagenase 3 - Pipeline Review, H1 2020 SUMMARY Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) pipeline Target constitutes close to 5 molecules. Out of which approximately 4 mol...
April 2020
60 pages
Estrogen Receptor Beta - Pipeline Review, H1 2020
US$ 3,500.00
Estrogen Receptor Beta - Pipeline Review, H1 2020 SUMMARY Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) pipeline Target constitutes close to 20 m...
April 2020
78 pages
Free Fatty Acid Receptor 1 - Pipeline Review, H1 2020
US$ 3,500.00
Free Fatty Acid Receptor 1 - Pipeline Review, H1 2020 SUMMARY Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) pipeline Target constitutes close to 16 molecules. Out of w...
April 2020
70 pages
Gamma Secretase - Pipeline Review, H1 2020
US$ 3,500.00
Gamma Secretase - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Gamma Secretase (EC 3.4.23.) - Pipeline Review, H1 2020'; Gamma Secretase (EC 3.4.23.) pipeline Target...
April 2020
77 pages
Growth/Differentiation Factor 8 - Pipeline Review, H1 2020
US$ 3,500.00
Growth/Differentiation Factor 8 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'GrowthDifferentiation Factor 8 - Pipeline Review, H1 2020'; Growth/Differentiation Fact...
April 2020
79 pages
Hepatocyte Growth Factor - Pipeline Review, H1 2020
US$ 3,500.00
Hepatocyte Growth Factor - Pipeline Review, H1 2020 SUMMARY Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) pipeline Target constitutes close to 15 molecules. The latest report H...
April 2020
80 pages
Histone Deacetylase 1 - Pipeline Review, H1 2020
US$ 3,500.00
Histone Deacetylase 1 - Pipeline Review, H1 2020 SUMMARY Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Histone deacetylase 1 is an enzyme encoded by the HDAC1 gene. The protein encoded by this gene...
April 2020
167 pages
Histone Deacetylase 2 - Pipeline Review, H1 2020
US$ 3,500.00
Histone Deacetylase 2 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Histone Deacetylase 2 - Pipeline Review, H1 2020'; Histone Deacetylase 2 (Transcriptional Regulat...
April 2020
145 pages
Histone Deacetylase 3 - Pipeline Review, H1 2020
US$ 3,500.00
Histone Deacetylase 3 - Pipeline Review, H1 2020 SUMMARY Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Histone deacetylase 3 is an enzyme encoded by the HDAC3 gene. Histone deac...
April 2020
105 pages
Matrix Metalloproteinase 9 - Pipeline Review, H1 2020
US$ 3,500.00
Matrix Metalloproteinase 9 - Pipeline Review, H1 2020 SUMMARY Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) - Matrix metallopep...
April 2020
53 pages
